We are live on ! Find out more
DIM

DC Investments Management Portfolio holdings

AUM $261M
1-Year Est. Return 20.71%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+20.71%
3 Year Est. Return
+44.71%
5 Year Est. Return
+36.74%
10 Year Est. Return
AUM
$157M
AUM Growth
+$8.18M
Cap. Flow
+$6.12M
Cap. Flow %
3.89%
Top 10 Hldgs %
6.71%
Holding
424
New
174
Increased
42
Reduced
68
Closed
139

Top Buys

Rank Stock Value
1
EVRG icon
Evergy
EVRG
+$1.09M
2
AER icon
AerCap
AER
+$863K
3
GRMN
Garmin
GRMN
+$838K
4
GSK icon
GSK
GSK
+$820K
5
SF
Stifel
SF
+$818K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.51M
2
AMGN icon
Amgen
AMGN
+$2.11M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.68M
4
NOC icon
Northrop Grumman
NOC
+$1.55M
5
BDX icon
Becton Dickinson
BDX
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 19.87%
2 Financials 19.67%
3 Technology 12.25%
4 Real Estate 10.82%
5 Utilities 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSCO icon
1
Cisco
CSCO
$443B
$1.71M 1.09%
39,659
+3,233
+9% +$141K
UNH icon
2
UnitedHealth
UNH
$382B
$1.34M 0.85%
5,466
-5,740
-51% -$1.38M
EVRG icon
3
Evergy
EVRG
$19.4B
$1.14M 0.73%
+20,319
New +$1.09M
ALL icon
4
Allstate
ALL
$70.6B
$1.08M 0.69%
11,878
+612
+5% +$58.2K
STE icon
5
Steris
STE
$22.9B
$923K 0.59%
8,794
+4,969
+130% +$500K
ACN icon
6
Accenture
ACN
$106B
$902K 0.57%
5,516
+3,249
+143% +$505K
AFL icon
7
Aflac
AFL
$65.5B
$877K 0.56%
20,390
+3,447
+20% +$155K
AER icon
8
AerCap
AER
$23.4B
$868K 0.55%
+16,024
New +$863K
INSP icon
9
Inspire Medical Systems
INSP
$1.47B
$857K 0.55%
+24,019
New +$775K
RDS.A
10
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$854K 0.54%
12,340
+7,084
+135% +$491K
GRMN
11
Garmin
GRMN
$56.9B
$851K 0.54%
+13,950
New +$838K
GS icon
12
Goldman Sachs
GS
$289B
$848K 0.54%
3,844
+817
+27% +$195K
TTE icon
13
TotalEnergies
TTE
$193B
$838K 0.53%
13,832
+9,989
+260% +$612K
E icon
14
ENI
E
$78.1B
$826K 0.53%
22,242
+12,086
+119% +$454K
GSK icon
15
GSK
GSK
$107B
$821K 0.52%
+16,290
New +$820K
SNN icon
16
Smith & Nephew
SNN
$13.7B
$814K 0.52%
+21,692
New +$806K
FMS icon
17
Fresenius Medical Care
FMS
$13.4B
$812K 0.52%
16,128
+9,590
+147% +$486K
ABT icon
18
Abbott
ABT
$188B
$805K 0.51%
13,195
+4,407
+50% +$267K
CL icon
19
Colgate-Palmolive
CL
$74.8B
$793K 0.5%
12,230
+6,658
+119% +$436K
NXPI icon
20
NXP Semiconductors
NXPI
$60.8B
$788K 0.5%
7,208
+1,857
+35% +$205K
TEL icon
21
TE Connectivity
TEL
$60B
$765K 0.49%
8,494
+5,791
+214% +$555K
NVO
22
Novo Nordisk
NVO
$228B
$760K 0.48%
32,972
+21,514
+188% +$511K
SCHW
23
Charles Schwab
SCHW
$182B
$738K 0.47%
+14,449
New +$800K
PS
24
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$734K 0.47%
+30,000
New +$721K
SF
25
Stifel
SF
$12.4B
$730K 0.46%
+31,433
New +$818K

Similar funds

DC Investments Management's Q2 2018 Portfolio in Review

As of Q2 2018, DC Investments Management held 424 positions worth $157M, up 5.5% from $149M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

DC Investments Management deployed $6.12M of net new capital in Q2 2018, opening 174 new positions and adding to 42 existing holdings. Its largest new stake was Evergy: 20,319 shares worth $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Pfizer, an estimated $2.51M trimmed.

  • DC Investments Management's largest Q2 2018 buy was Evergy: 20,319 shares worth $1.14M.
  • DC Investments Management added most to TotalEnergies in Q2 2018, an estimated $612K increase.
  • DC Investments Management's biggest Q2 2018 reduction was Pfizer, cutting an estimated $2.51M.
  • DC Investments Management fully exited Amgen in Q2 2018, selling an estimated $2.11M.
  • DC Investments Management's ten largest holdings make up 6.7% of its $157M portfolio in Q2 2018.
  • DC Investments Management opened 174 new positions and closed 139 in Q2 2018.
  • DC Investments Management's portfolio value rose 5.5% quarter-over-quarter to $157M.

Based on DC Investments Management's 13F filing for Q2 2018, filed 3 Aug 2018.